TOKYO--(BUSINESS WIRE)--FUJIFILM Corporation (President: Kenji Sukeno) is to invest a total of 3.2 billion yen on its CDMO *1 sites in the U.S.A. and the U.K. in order to accelerate the expansion of ...
Across biopharmaceutical development, LC-MS has been a foundational technology for the discovery and characterization of biotherapeutic attributes—including post-translational modifications such as ...
In process monitoring is important for optimizing cell culture conditions such as nutrient concentrations, cell viability, and metabolite production as well as product quality attributes such as ...
Collaboration to combine the Waters™ BioAccord™ LC-MS System as a bioprocess analyzer with the Sartorius Ambr ® bioreactor system gives bioprocess scientists both faster and direct access to advanced ...
Dublin, Dec. 13, 2024 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Process Analytical Technology Market by Product, Technology, Application, End-users and Region - Global Forecast 2025-2030" report has ...
Dublin, Dec. 18, 2025 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Process Analytical Technology Market - Global Forecast 2025-2030" has been added to ResearchAndMarkets.com's offering.
Biopharmaceutical Process and Quality Consortium (BPQC) is an interdisciplinary and multi-university research collaboration based on Massachusetts BioManufacturing Center at UMass Lowell. With a close ...
Oklahoma City, OK -- Cytovance Biologics, Inc. and Fountain BioPharma, Inc. jointly announce the execution of a Biopharmaceutical Development and Manufacturing collaboration for FB301, a novel ...
The biopharmaceutical industry faces strict regulations worldwide, making it essential to meet international standards before any new therapy can enter the market. Staying informed about the current ...
In May, Thomas Jefferson University opened the doors to a Philadelphia first — the Jefferson Institute for Bioprocessing (JIB). With the potential to help fill the local workforce gap, JIB is the only ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results